Both studies highlight the role of intervention measures in reducing inflammation, demonstrating that modulation of the TLR-4/NF-κB and other related signaling pathways can play a crucial anti-inflammatory and protective role in metabolic disorders associated with diabetes or obesity. Here, NFKB1 is linked to metabolic disease.